Scarica l'app Stockscreener
2.17
4.41%
-0.10
Dopo l'orario di chiusura:
2.24
0.07
+3.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$2.27
Aprire:
$2.22
Volume 24 ore:
4.67M
Relative Volume:
1.31
Capitalizzazione di mercato:
$489.47M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-1.4762
EPS:
-1.47
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
+9.05%
1M Prestazione:
+26.90%
6M Prestazione:
-21.94%
1 anno Prestazione:
-71.48%
Intervallo 1D:
$2.11
$2.2492
Intervallo di 1 settimana:
$1.975
$2.35
Portata 52W:
$1.26
$8.165
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
2.17 | 448.86M | 0 | -283.26M | -273.61M | -1.47 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Deutsche Bank AG Sells 72,413 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Reveals Latest Cell Therapy Progress at Jefferies and Goldman Sachs Healthcare Conferences - Stock Titan
Sana Biotechnology to Present at June 2025 Investor Conferences - GlobeNewswire
Jane Street Group LLC Boosts Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Sana Biotechnology’s SWOT analysis: engineered cell stock faces pivotal year By Investing.com - Investing.com South Africa
Northern Trust Corp Buys 60,004 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology’s SWOT analysis: engineered cell stock faces pivotal year - Investing.com Nigeria
Focus Partners Wealth Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Securities Lawsuit Alert: Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - The Malaysian Reserve
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Contact Levi & Korsinsky by May 20, 2025 to Join Class Action Against Sana Biotechnology, Inc. (SANA) - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment - Seeking Alpha
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, ... - Eagle-Tribune
SANA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
The End Of The Diabetes Industry?Eli Lilly (NYSE:LLY), DexCom (NASDAQ:DXCM) - Benzinga
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Sana Biotechnology, Inc. (SANA) Investors of May 20, 2025 Deadline - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
Investors in Sana Biotechnology, Inc. (SANA): Protect Your RightsContact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit ... - Bluefield Daily Telegraph
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
Securities Class Action Lawsuit Filed Against Sana Biotechnology, Inc. (SANA)Levi & Korsinsky Represents Shareholders - Louisiana First News
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
SANA Deadline: SANA Investors with Losses in Excess of $100K Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
2025-05-16 | Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 | NDAQ:SANA | Press Release - Stockhouse
Sana Biotechnology Inc (SANA) Should Be Considered For The Next Few Weeks - Stocksregister
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - WV News
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - The Malaysian Reserve
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
May 20, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SANA - Eagle-Tribune
Sana Biotechnology, Inc. (SANA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of May 20, 2025 Deadline - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Dimensional Fund Advisors LP Buys 478,596 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
May 20, 2025 Deadline Approaching: Join Class Action Against Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Before May 20, 2025Contact Levi & Korsinsky - Stockhouse
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Morningstar
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire Inc.
SANA Lawsuit Alert! Class Action Lawsuit Against Sana Biotechnology, Inc. - TipRanks
Sana Biotechnology, Inc. (NASDAQ: SANA) Investor Alert: Deadline in Lawsuit on May 20, 2025 - openPR.com
Transcript : Sana Biotechnology, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 09 - marketscreener.com
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
What Is The Outlook For Sana Biotechnology Inc (NASDAQ: SANA) Like For Short-Term? - Stocksregister
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):